A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Study Summary

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

Conditions

Hypochondroplasia

Interventions / Drugs

View on ClinicalTrials.gov ↗

Sponsor

BMRN

BioMarin Pharmaceutical

Rare Disease

D36/100

Study Details

Enrollment400 participants

Primary Completion—

Lead SponsorBioMarin Pharmaceutical

Data Retrieved2026-04-11 02:55:23.531576+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.